All 2026 2025 2024 2023 2022 2021 2020 2019 2018 April 22, 2026 Certara Enters Definitive Agreement for the Sale of its Regulatory Writing and Medical Writing Business to Veristat April 9, 2026 Certara to Report First Quarter 2026 Financial Results on May 11th, 2026 March 3, 2026 Certara Simcyp® Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML) Therapy asciminib February 27, 2026 Certara to Participate in Upcoming Investor Conferences February 26, 2026 Certara Reports Fourth Quarter 2025 Financial Results; Provides Full Year 2026 Guidance January 29, 2026 Certara to Report Fourth Quarter and Full Year 2025 Financial Results on February 26th, 2026
April 22, 2026 Certara Enters Definitive Agreement for the Sale of its Regulatory Writing and Medical Writing Business to Veristat
March 3, 2026 Certara Simcyp® Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML) Therapy asciminib
February 26, 2026 Certara Reports Fourth Quarter 2025 Financial Results; Provides Full Year 2026 Guidance
January 29, 2026 Certara to Report Fourth Quarter and Full Year 2025 Financial Results on February 26th, 2026
